(2019) WHO Classification of Tumours: Digestive system tumours Fifth Edition. International Agency for Research on Cancer; 2019

Alizadeh AA, Aranda V, Bardelli A, Blanpain C, Bock C, Borowski C, Caldas C, Califano A, Doherty M, Elsner M, Esteller M, Fitzgerald R, Korbel JO, Lichter P, Mason CE, Navin N, Pe'er D, Polyak K, Roberts CW, Siu L, Snyder A, Stower H, Swanton C, Verhaak RG, Zenklusen JC, Zuber J, Zucman-Rossi J (2015) Toward understanding and exploiting tumor heterogeneity Nat Med 21:846-853. https://doi.org/10.1038/nm.3915

Bosman FT (2018) Tumor Heterogeneity: Will It Change What Pathologists Do. Pathobiology 85:18–22. https://doi.org/10.1159/000469664

Article  PubMed  Google Scholar 

Burrell RA, Swanton C (2014) Tumour heterogeneity and the evolution of polyclonal drug resistance. Mol Oncol 8:1095–1111. https://doi.org/10.1016/j.molonc.2014.06.005

Article  CAS  PubMed  PubMed Central  Google Scholar 

Canellas-Socias A, Sancho E, Batlle E (2024) Mechanisms of metastatic colorectal cancer. Nat Rev Gastroenterol Hepatol 21:609–625. https://doi.org/10.1038/s41575-024-00934-z

Article  PubMed  Google Scholar 

Chen J, Larsson L, Swarbrick A, Lundeberg J (2024) Spatial landscapes of cancers: insights and opportunities. Nat Rev Clin Oncol 21:660–674. https://doi.org/10.1038/s41571-024-00926-7

Article  PubMed  Google Scholar 

Dagogo-Jack I, Shaw AT (2018) Tumour heterogeneity and resistance to cancer therapies. Nat Rev Clin Oncol 15:81–94. https://doi.org/10.1038/nrclinonc.2017.166

Article  CAS  PubMed  Google Scholar 

Demicco M, Liu XZ, Leithner K, Fendt SM (2024) Metabolic heterogeneity in cancer Nat Metab 6:18–38. https://doi.org/10.1038/s42255-023-00963-z

Article  PubMed  Google Scholar 

Fearon ER, Carethers JM (2015) Molecular subtyping of colorectal cancer: time to explore both intertumoral and intratumoral heterogeneity to evaluate patient outcome. Gastroenterology 148:10–13. https://doi.org/10.1053/j.gastro.2014.11.024

Article  PubMed  Google Scholar 

Frizziero M, Wang X, Chakrabarty B, Childs A, Luong TV, Walter T, Khan MS, Morgan M, Christian A, Elshafie M, Shah T, Minicozzi A, Mansoor W, Meyer T, Lamarca A, Hubner RA, Valle JW, McNamara MG (2019) Retrospective study on mixed neuroendocrine non-neuroendocrine neoplasms from five European centres. World J Gastroenterol 25:5991–6005. https://doi.org/10.3748/wjg.v25.i39.5991

Article  CAS  PubMed  PubMed Central  Google Scholar 

Griger J, Widholz SA, Jesinghaus M, de Andrade Kratzig N, Lange S, Engleitner T, Montero JJ, Zhigalova E, Ollinger R, Suresh V, Winkler W, Lier S, Baranov O, Trozzo R, Ben Khaled N, Chakraborty S, Yu J, Konukiewitz B, Steiger K, Pfarr N, Rajput A, Sailer D, Keller G, Schirmacher P, Rocken C, Fagerstedt KW, Mayerle J, Schmidt-Supprian M, Schneider G, Weichert W, Calado DP, Sommermann T, Kloppel G, Rajewsky K, Saur D, Rad R (2023) An integrated cellular and molecular model of gastric neuroendocrine cancer evolution highlights therapeutic targets. Cancer Cell 41: 1327–1344 e1310. https://doi.org/10.1016/j.ccell.2023.06.001

Jesinghaus M, Konukiewitz B, Keller G, Kloor M, Steiger K, Reiche M, Penzel R, Endris V, Arsenic R, Hermann G, Stenzinger A, Weichert W, Pfarr N, Kloppel G (2017) Colorectal mixed adenoneuroendocrine carcinomas and neuroendocrine carcinomas are genetically closely related to colorectal adenocarcinomas Mod Pathol 30:610-619. https://doi.org/10.1038/modpathol.2016.220

Article  CAS  PubMed  Google Scholar 

Jesinghaus M, Schmitt M, Lang C, Reiser M, Scheiter A, Konukiewitz B, Steiger K, Silva M, Tschurtschenthaler M, Lange S, Foersch S, Becker KF, Saur D, Friess H, Halfter K, Engel J, Boxberg M, Pfarr N, Wilhelm D, Weichert W (2021) Morphology Matters: A Critical Reappraisal of the Clinical Relevance of Morphologic Criteria From the 2019 WHO Classification in a Large Colorectal Cancer Cohort Comprising 1004 Cases Am J Surg Pathol 45:969–978. https://doi.org/10.1097/pas.0000000000001692

Ji M, Fan D, Yuan Y, Wang J, Feng X, Yang W, Dang X, Xu Y, Wang J (2025) Investigation into the Spatial Heterogeneity of Lung Composite Large-Cell Neuroendocrine Carcinoma Spatial Transcriptomic Analysis of Combined Large-Cell Neuroendocrine Carcinoma Cancer Biother Radiopharm. https://doi.org/10.1089/cbr.2025.0043

Koh J, Nam SK, Kwak Y, Kim G, Kim KK, Lee BC, Ahn SH, Park DJ, Kim HH, Park KU, Kim WH, Lee HS (2021) Comprehensive genetic features of gastric mixed adenoneuroendocrine carcinomas and pure neuroendocrine carcinomas. J Pathol 253:94–105. https://doi.org/10.1002/path.5556

Article  CAS  PubMed  Google Scholar 

Konukiewitz B, Jesinghaus M, Steiger K, Schlitter AM, Kasajima A, Sipos B, Zamboni G, Weichert W, Pfarr N, Kloppel G (2018) Pancreatic neuroendocrine carcinomas reveal a closer relationship to ductal adenocarcinomas than to neuroendocrine tumors G3 Hum Pathol 77:70–79. https://doi.org/10.1016/j.humpath.2018.03.018

Konukiewitz B, Kasajima A, Schmitt M, Schwamborn K, Groll T, Schicktanz F, Delbridge C, Schutze LM, Wilhelm D, Lang C, Lange S, Foersch S, Jank P, Steiger K, Werder AV, Denkert C, Weichert W, Kloppel G, Jesinghaus M (2021) Neuroendocrine Differentiation in Conventional Colorectal Adenocarcinomas: Incidental Finding or Prognostic Biomarker? Cancers (Basel) 13. https://doi.org/10.3390/cancers13205111

Kraemer M, Zander T, Alakus H, Buettner R, Lyu SI, Simon AG, Schroeder W, Bruns CJ, Quaas A (2024) Fetal gut cell-like differentiation in esophageal adenocarcinoma defines a rare tumor subtype with therapeutically relevant claudin-6 positivity and SWI/SNF gene alteration Sci Rep 14:13474. https://doi.org/10.1038/s41598-024-64116-2

Kwak Y, Nam SK, Park Y, Suh YS, Ahn SH, Kong SH, Park DJ, Lee HJ, Kim HH, Yang HK, Lee HS (2024) Distinctive Phenotypic and Microenvironmental Characteristics of Neuroendocrine Carcinoma and Adenocarcinoma Components in Gastric Mixed Adenoneuroendocrine Carcinoma. Mod Pathol 37. https://doi.org/10.1016/j.modpat.2024.100568

La Rosa S, Marando A, Sessa F, Capella C (2012) Mixed Adenoneuroendocrine Carcinomas (MANECs) of the Gastrointestinal Tract: An Update Cancers (Basel) 4:11–30. https://doi.org/10.3390/cancers4010011

Litmeyer AS, Konukiewitz B, Kasajima A, Foersch S, Schicktanz F, Schmitt M, Kellers F, Grass A, Jank P, Lehman B, Gress TM, Rinke A, Bartsch DK, Denkert C, Weichert W, Kloppel G, Jesinghaus M (2023) High expression of insulinoma-associated protein 1 (INSM1) distinguishes colorectal mixed and pure neuroendocrine carcinomas from conventional adenocarcinomas with diffuse expression of synaptophysin J Pathol Clin Res 9:498–509. https://doi.org/10.1002/cjp2.339

Rao A, Barkley D, Franca GS, Yanai I (2021) Exploring tissue architecture using spatial transcriptomics Nature 596:211–220. https://doi.org/10.1038/s41586-021-03634-9

Article  CAS  PubMed  Google Scholar 

Thakur S, Haider S, Natrajan R (2023) Implications of tumour heterogeneity on cancer evolution and therapy resistance: lessons from breast cancer. J Pathol 260:621–636. https://doi.org/10.1002/path.6158

Article  CAS  PubMed  Google Scholar 

Uccella S, La Rosa S (2020) Looking into digestive mixed neuroendocrine - nonneuroendocrine neoplasms: subtypes, prognosis, and predictive factors Histopathology 77:700–717. https://doi.org/10.1111/his.14178

Walter T, Lievre A, Coriat R, Malka D, Elhajbi F, Di Fiore F, Hentic O, Smith D, Hautefeuille V, Roquin G, Perrier M, Dahan L, Granger V, Sobhani I, Mineur L, Niccoli P, Assenat E, Scoazec JY, Le Malicot K, Lepage C, Lombard-Bohas C (2023) Bevacizumab plus FOLFIRI after failure of platinum-etoposide first-line chemotherapy in patients with advanced neuroendocrine carcinoma (PRODIGE 41-BEVANEC): a randomised, multicentre, non-comparative, open-label, phase 2 trial Lancet Oncol 24:297–306. https://doi.org/10.1016/s1470-2045(23)00001-3

Weaver JMJ, Hubner RA, Valle JW, McNamara MG (2023) Selection of Chemotherapy in Advanced Poorly Differentiated Extra-Pulmonary Neuroendocrine Carcinoma Cancers (Basel) 15. https://doi.org/10.3390/cancers15204951

Woischke C, Schaaf CW, Yang HM, Vieth M, Veits L, Geddert H, Markl B, Stommer P, Schaeffer DF, Frolich M, Blum H, Vosberg S, Greif PA, Jung A, Kirchner T, Horst D (2017) In-depth mutational analyses of colorectal neuroendocrine carcinomas with adenoma or adenocarcinoma components. Mod Pathol 30:95–103. https://doi.org/10.1038/modpathol.2016.150

Article  CAS  PubMed  Google Scholar 

Yamaguchi T, Machida N, Morizane C, Kasuga A, Takahashi H, Sudo K, Nishina T, Tobimatsu K, Ishido K, Furuse J, Boku N, Okusaka T (2014) Multicenter retrospective analysis of systemic chemotherapy for advanced neuroendocrine carcinoma of the digestive system. Cancer Sci 105:1176–1181. https://doi.org/10.1111/cas.12473

Article  CAS  PubMed  PubMed Central  Google Scholar 

Yoo M, Shin J, Kim J, Ryall KA, Lee K, Lee S, Jeon M, Kang J, Tan AC (2015) DSigDB: drug signatures database for gene set analysis Bioinformatics 31:3069–3071. https://doi.org/10.1093/bioinformatics/btv313